Increased expression of hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels in reactive astrocytes following ischemia

Authors:

Abstract
Astrocytes respond to ischemic brain injury by proliferation, the increased expression of intermediate filaments and hypertrophy, which results in glial scar formation. In addition, they alter the expression of ion channels, receptors and transporters that maintain ionic/neurotransmitter homeostasis. Here, we aimed to demonstrate the expression ofHcn1–4genes encoding hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels in reactive astrocytes following focal cerebral ischemia (FCI) or global cerebral ischemia (GCI) and to characterize their functional properties. A permanent occlusion of the middle cerebral artery (MCAo) was employed to induce FCI in adult GFAP/EGFP mice, while GCI was induced by transient bilateral common carotid artery occlusion combined with hypoxia in adult rats. Using FACS, we isolated astrocytes from non‐injured or ischemic brains and performed gene expression profiling using single‐cell RT‐qPCR. We showed that 2 weeks after ischemia reactive astrocytes express high levels ofHcn1–4transcripts, while immunohistochemical analyses confirmed the presence of HCN1–3 channels in reactive astrocytes 5 weeks after ischemia. Electrophysiological recordings revealed that post‐ischemic astrocytes are significantly depolarized, and compared with astrocytes from non‐injured brains, they display large hyperpolarization‐activated inward currents, the density of which increased 2–3‐fold in response to ischemia. Their activation was facilitated by cAMP and their amplitudes were decreased by ZD7288 or low extracellular Na+concentration, suggesting that they may belong to the family of HCN channels. Collectively, our results demonstrate that regardless of the type of ischemic injury, reactive astrocytes express HCN channels, which could therefore be an important therapeutic target in poststroke therapy. GLIA 2014;62:2004–2021
Funding Information
  • Czech Science Foundation (CZ: GA CR: P303 13-02154S, CZ: GACR: P304/12/G069)
  • Czech Science Foundation (UEM AV CR AV0Z50390703)
  • BIOCEV Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University-European Regional Development Fund (CZ.1.05/1.1.00/02.0109)
  • European Social Fund Plus (CZ.1.07/2.3.00/30.0045)

This publication has 55 references indexed in Scilit: